BKNG(BKNG)
BKNG
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $29.26B | $32.00B | $34.63B | $38.16B | $40.82B |
| Low | $29.08B | $31.21B | $33.00B | $37.30B | $39.90B |
| High | $29.47B | $32.53B | $36.47B | $39.24B | $41.97B |
| EBITDA Avg | $14.31B | $15.65B | $16.93B | $18.67B | $19.96B |
| Low | $14.22B | $15.26B | $16.14B | $18.24B | $19.51B |
| High | $14.41B | $15.91B | $17.84B | $19.19B | $20.53B |
| EBIT Avg | $14.03B | $15.35B | $16.61B | $18.30B | $19.58B |
| Low | $13.95B | $14.97B | $15.83B | $17.89B | $19.13B |
| High | $14.13B | $15.60B | $17.49B | $18.82B | $20.13B |
| Net Income Avg | $8.64B | $10.15B | $10.27B | $14.20B | $16.42B |
| Low | $8.33B | $9.78B | $9.92B | $13.79B | $15.94B |
| High | $8.94B | $10.53B | $12.47B | $14.72B | $17.02B |
| EPS Avg | $10.45 | $12.39 | $14.33 | $17.41 | $20.12 |
| Low | $10.21 | $11.98 | $12.16 | $16.89 | $19.53 |
| High | $10.96 | $12.91 | $15.28 | $18.04 | $20.86 |
| Analysts (Rev / EPS) | 27 / 25 | 28 / 26 | 22 / 18 | 14 / 9 | 11 / 8 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $9.54B | $6.81B | $5.95B | $8.05B | $10.48B | $7.47B | $6.40B | $8.54B |
| Low | $9.44B | $6.66B | $5.85B | $7.92B | $10.31B | $7.34B | $6.29B | $8.40B |
| High | $9.73B | $6.93B | $6.10B | $8.25B | $10.74B | $7.65B | $6.56B | $8.76B |
| EBITDA Avg | $4.67B | $3.33B | $2.91B | $3.94B | $5.13B | $3.65B | $3.13B | $4.18B |
| Low | $4.62B | $3.26B | $2.86B | $3.87B | $5.04B | $3.59B | $3.08B | $4.11B |
| High | $4.76B | $3.39B | $2.98B | $4.04B | $5.25B | $3.74B | $3.21B | $4.28B |
| EBIT Avg | $4.57B | $3.27B | $2.85B | $3.86B | $5.03B | $3.58B | $3.07B | $4.10B |
| Low | $4.53B | $3.19B | $2.80B | $3.80B | $4.94B | $3.52B | $3.02B | $4.03B |
| High | $4.67B | $3.32B | $2.92B | $3.96B | $5.15B | $3.67B | $3.14B | $4.20B |
| Net Income Avg | $3.45B | $1.78B | $1.08B | $2.25B | $3.99B | $2.12B | $1.31B | $2.64B |
| Low | $3.30B | $1.68B | $1.05B | $2.20B | $3.91B | $2.08B | $1.29B | $2.59B |
| High | $3.58B | $1.98B | $1.11B | $2.32B | $4.12B | $2.19B | $1.36B | $2.73B |
| EPS Avg | $4.48 | $2.31 | $1.40 | $2.92 | $5.18 | $2.75 | $1.71 | $3.43 |
| Low | $4.29 | $2.18 | $1.37 | $2.86 | $5.07 | $2.69 | $1.67 | $3.36 |
| High | $4.65 | $2.57 | $1.44 | $3.02 | $5.35 | $2.84 | $1.76 | $3.54 |
| Analysts (Rev / EPS) | 19 / 17 | 19 / 16 | 9 / 8 | 9 / 7 | 9 / 7 | 15 / 12 | 13 / 9 | 9 / 8 |